Event occurred in (b)(6).Valve thrombosis, post-operative - late.The adverse event was first discovered in a journal article, (b)(6).The article makes the point that the thrombus on the stuck-closed leaflet could not be detected by tte, but could by using multidetector-row computed tomography.On (b)(6) 2015, onxlti received a set of date from the sponsor of a (b)(6) post-market study, where-in they wanted on-x to do data analysis on a set data containing adverse events.The valve on this mdr is one of the ae's.The thrombosis was corrected by thrombectomy via arterial shunt.Inr on date of event was subtherapeutic at 1.4.Valve thrombosis is by definition in the aats/sts guidelines a valve-related event and is therefore, reportable.It is an expected adverse event, as defined in the objective performance criteria in fda heart valve guidance, and iso 5840, and this occurrence is well-within expected rate.No trend is seen.
|
The valve remains implanted and functioning normally.The valve was not explanted so no serious injury, the valve had 1 leaflet stuck closed due to the thrombus, which was corrected medicinally, using thrombectomy administered via arterial shunt.Review of factory device history records shows the device was built per specs.
|